Symphony vs Opera Which Is More Lucrative?

Symphony vs Opera stocks are a comparison of two different types of companies within the music and entertainment industries. Symphony stocks typically represent companies involved in producing and performing orchestral music, while Opera stocks are tied to companies focused on staging and performing opera productions. Both industries have unique investment opportunities and challenges, with Symphony stocks often influenced by ticket sales and music trends, while Opera stocks may be impacted by the popularity of specific operas and production costs. Investors interested in the music sector should carefully evaluate the financial performance and growth potential of Symphony vs Opera stocks to make informed investment decisions.

Symphony

Opera

Stock Price
Day LowHK$0.79
Day HighHK$0.80
Year LowHK$0.78
Year HighHK$0.92
Yearly Change17.95%
Revenue
Revenue Per ShareHK$0.10
5 Year Revenue Growth-0.20%
10 Year Revenue Growth-0.29%
Profit
Gross Profit Margin0.75%
Operating Profit Margin0.05%
Net Profit Margin-0.49%
Stock Price
Day Low$19.00
Day High$20.23
Year Low$10.11
Year High$20.70
Yearly Change104.75%
Revenue
Revenue Per Share$5.07
5 Year Revenue Growth1.61%
10 Year Revenue Growth2.94%
Profit
Gross Profit Margin0.53%
Operating Profit Margin0.19%
Net Profit Margin0.36%

Symphony

Opera

Financial Ratios
P/E ratio-16.22
PEG ratio-0.16
P/B ratio0.98
ROE-5.91%
Payout ratio-10.14%
Current ratio1.01
Quick ratio0.98
Cash ratio0.04
Dividend
Dividend Yield0.62%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
Symphony Dividend History
Financial Ratios
P/E ratio10.75
PEG ratio0.75
P/B ratio1.88
ROE17.45%
Payout ratio23.59%
Current ratio2.10
Quick ratio2.10
Cash ratio1.15
Dividend
Dividend Yield4.02%
5 Year Dividend Yield0.00%
10 Year Dividend Yield0.00%
Opera Dividend History

Symphony or Opera?

When comparing Symphony and Opera, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Symphony and Opera.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Symphony has a dividend yield of 0.62%, while Opera has a dividend yield of 4.02%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Symphony reports a 5-year dividend growth of 0.00% year and a payout ratio of -10.14%. On the other hand, Opera reports a 5-year dividend growth of 0.00% year and a payout ratio of 23.59%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Symphony P/E ratio at -16.22 and Opera's P/E ratio at 10.75. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Symphony P/B ratio is 0.98 while Opera's P/B ratio is 1.88.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Symphony has seen a 5-year revenue growth of -0.20%, while Opera's is 1.61%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Symphony's ROE at -5.91% and Opera's ROE at 17.45%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are HK$0.79 for Symphony and $19.00 for Opera. Over the past year, Symphony's prices ranged from HK$0.78 to HK$0.92, with a yearly change of 17.95%. Opera's prices fluctuated between $10.11 and $20.70, with a yearly change of 104.75%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.

Comparision